(2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol
C27H27FN2O3 — CID 155556316
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol
(2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol (PubChem CID 155556316) has the molecular formula C27H27FN2O3 and a molecular weight of 446.52 g/mol. Its IUPAC name is (2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol.
Molecular Properties
| Compound Name | (2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol |
|---|---|
| PubChem CID | 155556316 |
| Molecular Formula | C27H27FN2O3 |
| Molecular Weight | 446.52 g/mol |
| Exact Mass | 446.20 |
| IUPAC Name | (2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-4-methyl-3-pyridin-3-yl-2H-chromen-6-ol |
| SMILES | CC1=C(c2cccnc2)[C@H](c2ccc(OCCN3CC(CF)C3)cc2)Oc2ccc(O)cc21 |
| InChI | InChI=1S/C27H27FN2O3/c1-18-24-13-22(31)6-9-25(24)33-27(26(18)21-3-2-10-29-15-21)20-4-7-23(8-5-20)32-12-11-30-16-19(14-28)17-30/h2-10,13,15,19,27,31H,11-12,14,16-17H2,1H3/t27-/m0/s1 |
| InChIKey | AXAYUDSEZWBHKO-MHZLTWQESA-N |
| XLogP | 5.13 |
| TPSA | 54.82 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.52 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155556316 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.